Cameron Durrant is listed as an executive officer and director on 4 SEC Form D filings by 1 issuer between Jul 2016 and Nov 2019: HUMANIGEN, INC (Burlingame, CA — pharmaceuticals — 2016–2019; $17M reported sold to 18 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Ronald Barliant (4 shared filings), Timothy Morris (4 shared filings), Dale Chappell (2 shared filings), Ezra Friedberg (2 shared filings), Greg Jester (2 shared filings) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Cameron. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Cameron Durrant and found 10 differences, 2 worth asking the sponsor about: Regulator action naming a team member: Dale B. Chappell, et al. (Dec 31, 2024); Regulator action naming a team member: Michael E. Lopuszynski, C. Scott Courtney, Jonathan Shoucair, Michael W. Englehardt, Joseph Widmer, Kent Bollenbach, Timothy Graysonbrent Morris and James Perez (Apr 13, 1998); and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.